NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Biochemistry/Enzymes
    Enzymes
    medium
    flask-conical Biochemistry

    In Menke’s disease, which of the following enzymes would be affected?

    A. Prolyl oxidase
    B. Prolyl hydroxylase
    C. Lysyl hydroxylase
    D. Lysyl oxidase

    Explanation

    ## Correct Answer: D. Lysyl oxidase Menkes disease is an **X-linked recessive disorder of copper metabolism** caused by mutations in the ATP7A gene, which encodes a copper-transporting ATPase. This defect impairs copper delivery to cuproenzymes throughout the body. **Lysyl oxidase** is a copper-dependent enzyme essential for cross-linking collagen and elastin by oxidizing lysine and hydroxylysine residues to aldehydes (allysine and hydroxyallysine), which then spontaneously condense to form Schiff bases and aldol products. Without adequate copper, lysyl oxidase activity is severely reduced, leading to defective collagen and elastin cross-linking. This explains the clinical hallmarks of Menkes disease: connective tissue fragility (kinky hair, skin laxity, vascular rupture), bone abnormalities (osteoporosis, metaphyseal spurs), and neurological deterioration (due to defective dopamine β-hydroxylase and cytochrome c oxidase, also copper-dependent). The diagnosis is confirmed by low serum copper and ceruloplasmin levels. Early copper supplementation (copper histidinate or copper chloride) may slow progression if initiated before neurological damage becomes irreversible. ## Why the other options are wrong **A. Prolyl oxidase** — Prolyl oxidase is not a recognized enzyme in collagen metabolism. The correct enzyme involved in proline modification is **prolyl hydroxylase** (which requires vitamin C and iron, not copper), which hydroxylates proline residues *after* collagen synthesis. This is a distractor that confuses students unfamiliar with the distinction between hydroxylation (vitamin C-dependent) and oxidative cross-linking (copper-dependent) steps in collagen maturation. **B. Prolyl hydroxylase** — Prolyl hydroxylase is a **vitamin C and iron-dependent enzyme**, not copper-dependent. It hydroxylates proline to hydroxyproline in the collagen triple helix, which is essential for stability but occurs *before* cross-linking. Menkes disease does not affect this enzyme; patients with vitamin C deficiency (scurvy) show prolyl hydroxylase deficiency. This option tests whether students confuse the two distinct enzymatic steps in collagen maturation. **C. Lysyl hydroxylase** — Lysyl hydroxylase is also **vitamin C and iron-dependent** (not copper-dependent) and hydroxylates lysine residues to hydroxylysine in collagen. While hydroxylysine is the substrate for lysyl oxidase cross-linking, the hydroxylase itself is not affected in Menkes disease. This is a classic NBE trap: both lysyl hydroxylase and lysyl oxidase involve lysine, but only the latter is copper-dependent and affected in Menkes disease. ## High-Yield Facts - **Menkes disease** = X-linked copper malabsorption → defective lysyl oxidase → defective collagen/elastin cross-linking - **Lysyl oxidase** is copper-dependent; catalyzes oxidation of lysine/hydroxylysine to aldehydes for cross-link formation - **Prolyl hydroxylase and lysyl hydroxylase** are vitamin C + iron-dependent, NOT copper-dependent; unaffected in Menkes disease - **Clinical triad of Menkes**: kinky hair (connective tissue fragility), vascular rupture (aortic aneurysm risk), neurological decline (seizures, developmental regression) - **Diagnosis**: low serum copper, low ceruloplasmin, elevated urine copper; genetic testing for ATP7A mutations confirms - **Treatment**: early copper supplementation (copper histidinate IV or oral copper chloride) may prevent neurological progression if started before 6 weeks of age ## Mnemonics **Cu-dependent vs. Vit C-dependent in Collagen** **Cu-LOX** (Lysyl Oxidase = copper) vs. **VitC-ProHy/LysHy** (Prolyl/Lysyl Hydroxylase = vitamin C). Cross-linking needs copper; hydroxylation needs vitamin C. **Menkes = Kinky Hair + Copper** **M**enkes → **M**etal (copper) defect → **M**essed-up collagen cross-links → **M**anifests as kinky hair, vascular fragility, neurodegeneration. Use when you see 'kinky hair disease.' ## NBE Trap NBE pairs "lysine" with both lysyl hydroxylase and lysyl oxidase to trap students who recognize lysine involvement but don't distinguish between vitamin C-dependent hydroxylation and copper-dependent oxidative cross-linking. The presence of "lysyl" in three options (B, C, D) further obscures the copper-dependency distinction. ## Clinical Pearl In Indian pediatric practice, Menkes disease typically presents in the first 2–3 months of life with poor feeding, developmental delay, and characteristic "steely" or kinky hair. Early recognition and copper supplementation (copper histidinate 50–100 µg/kg/day IV) can prevent catastrophic neurological deterioration; delayed diagnosis often results in severe seizures and death by age 3. Genetic counseling for X-linked inheritance is critical in affected families. _Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 3 (Genetic Disorders); Harper's Biochemistry, Ch. 49 (Collagen); KD Tripathi Pharmacology, Ch. 57 (Trace Elements)_

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Biochemistry Questions